Advanced Natural Language Processing with TensorFlow 2

por Bansal, Ashish
Publicado 2021

An unusual case of low-grade tubulopapillary adenocarcinoma of the sinonasal tract

por Bansal, Ashish, Pradeep, Keloth E, Gumparthy, Krishna P
Publicado 2008

Correlation of Fetal Anterior Abdominal Wall Thickness and Other Standard Biometric Ultrasound Measurements to Predict Fetal Macrosomia in Gestational Diabetes

por Bansal, Ashish, Thukral, Brij Bhushan, Bagri, Neha, Kanwar, Ankita, Khandelwal, Ayush, Bajaj, Bindu
Publicado 2022

Nomenclature and clinical phenotypes of atopic dermatitis

por Girolomoni, Giampiero, de Bruin-Weller, Marjolein, Aoki, Valeria, Kabashima, Kenji, Deleuran, Mette, Puig, Luis, Bansal, Ashish, Rossi, Ana B.
Publicado 2021

Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data

por Kovalenko, Pavel, Kamal, Mohamed A., Davis, John D., Huniti, Nidal, Xu, Christine, Bansal, Ashish, Shumel, Brad, DiCioccio, A. Thomas
Publicado 2021

Is central pancreatectomy an effective alternative to distal pancreatectomy for low-grade pancreatic neck and body tumors: A 20-year single-center propensity score-matched case-con...

por Bansal, Ashish Kumar, Nagari, Bheerappa, Nekarakanti, Phani Kumar, Pakkala, Amith Kumar, Thumma, Venu Madhav, Gunturi, Surya Ramachandra Varma, Pardasani, Madhur
Publicado 2023

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis

por Simpson, Eric L., de Bruin-Weller, Marjolein, Bansal, Ashish, Chen, Zhen, Nelson, Lauren, Whalley, Diane, Prescilla, Randy, Guillemin, Isabelle, Delevry, Dimittri
Publicado 2021

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

por Davis, John D., Bansal, Ashish, Hassman, David, Akinlade, Bolanle, Li, Meng, Li, Zhaoyang, Swanson, Brian, Hamilton, Jennifer D., DiCioccio, A. Thomas
Publicado 2018

Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children’s Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis

por Simpson, Eric L., de Bruin-Weller, Marjolein, Eckert, Laurent, Whalley, Diane, Guillemin, Isabelle, Reaney, Matthew, Chen, Zhen, Nelson, Lauren, Qin, Shanshan, Bansal, Ashish, Gadkari, Abhijit
Publicado 2019

Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years

por Siegfried, Elaine C., Simpson, Eric L., Cork, Michael J., Arkwright, Peter D., Wine Lee, Lara, Chen, Zhen, Prescilla, Randy, Bansal, Ashish, Levit, Noah A., Rodríguez Marco, Ainara
Publicado 2023

Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis

por Paller, Amy S., Siegfried, Elaine C., Cork, Michael J., Wollenberg, Andreas, Arkwright, Peter D., Gonzalez, Mercedes E., Lockshin, Benjamin, Chen, Zhen, Bansal, Ashish, Levit, Noah A., Prescilla, Randy
Publicado 2022

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis

por Paller, Amy S., Yosipovitch, Gil, Weidinger, Stephan, DiBenedetti, Dana, Whalley, Diane, Gadkari, Abhijit, Guillemin, Isabelle, Zhang, Haixin, Eckert, Laurent, Chao, Jingdong, Bansal, Ashish, Chuang, Chien-Chia, Delevry, Dimittri
Publicado 2022

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis

por Cork, Michael J., Thaçi, Diamant, Eichenfield, Lawrence F., Arkwright, Peter D., Chen, Zhen, Thomas, Ryan B., Kosloski, Matthew P., Dubost-Brama, Ariane, Prescilla, Randy, Bansal, Ashish, Levit, Noah A.
Publicado 2023

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data

por Paller, Amy S., Beck, Lisa A., Blauvelt, Andrew, Siegfried, Elaine C., Cork, Michael J., Wollenberg, Andreas, Chen, Zhen, Khokhar, Faisal A., Vakil, Jignesh, Zhang, Annie, Bansal, Ashish, Cyr, Sonya L.
Publicado 2022

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use

por DELEURAN, Mette, MARCOUX, Danielle, DE BRUIN-WELLER, Marjolein S., IRVINE, Alan D., BASELGA, Eulalia, AHN, Kangmo, CASTRO, Ana Paula, BANSAL, Ashish, CHAO, Jingdong, BÉGO-LE BAGOUSSE, Gaëlle, ROSSI, Ana B.
Publicado 2021

Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial

por Siegfried, Elaine C., Bieber, Thomas, Simpson, Eric L., Paller, Amy S., Beck, Lisa A., Boguniewicz, Mark, Schneider, Lynda C., Khokhar, Faisal A., Chen, Zhen, Prescilla, Randy, Mina-Osorio, Paola, Bansal, Ashish
Publicado 2021

Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older

por Simpson, Eric L., Paller, Amy S., Siegfried, Elaine C., Thaçi, Diamant, Wollenberg, Andreas, Cork, Michael J., Marcoux, Danielle, Huang, Rui, Chen, Zhen, Rossi, Ana B., Shumel, Brad, Sierka, Debra, Bansal, Ashish
Publicado 2021

Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials

por Paller, Amy S., Silverberg, Jonathan I., Cork, Michael J., Guttman-Yassky, Emma, Lockshin, Benjamin, Irvine, Alan D., Kim, Moon Bum, Kabashima, Kenji, Chen, Zhen, Lu, Yufang, Bansal, Ashish, Rossi, Ana B., Shabbir, Arsalan
Publicado 2023

Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial

por Paller, Amy S., Wollenberg, Andreas, Siegfried, Elaine, Thaçi, Diamant, Cork, Michael J., Arkwright, Peter D., Gooderham, Melinda, Sun, Xian, O’Malley, John T., Khokhar, Faisal A., Vakil, Jignesh, Bansal, Ashish, Rosner, Karli, Shumel, Brad, Levit, Noah A.
Publicado 2021

Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD...

por Blauvelt, Andrew, Guttman-Yassky, Emma, Paller, Amy S., Simpson, Eric L., Cork, Michael J., Weisman, Jamie, Browning, John, Soong, Weily, Sun, Xian, Chen, Zhen, Kosloski, Matthew P., Kamal, Mohamed A., Delevry, Dimittri, Chuang, Chien-Chia, O’Malley, John T., Bansal, Ashish
Publicado 2022